Research Library

Premium Loss of heterozygosity on chromosome 14 in nasopharyngeal carcinoma
Mutirangura Apiwat,
Pornthanakasem Wichai,
Sriuranpong Virote,
Supiyaphun Pakpoom,
Voravud Narin
Publication year1998
Publication title
international journal of cancer
Resource typeJournals
PublisherWiley Subscription Services
Abstract The main objective of this study was to determine the precise frequency of chromosome 14q loss of heterozygosity in nasopharyngeal carcinomas and to define its minimal deletion regions. Thirty‐nine tumors were selected for PCR‐based deletion mapping using 19 microsatellite polymorphic markers spanning the long arm of this chromosome. Loss of heterozygosity for at least one marker was observed in 29 (74.4%) tumors, while 24 of these tumors displayed partial loss and provided an informative basis for detailed deletion mapping. Three minimal regions of loss were delineated, the first defined by markers D14S278 and D14S288, the second being between D14S51 and the telomere. These data confirmed 2 potential tumor‐suppressor‐gene loci at 14q12‐13 and 14 q32. Interestingly, the third region of loss was located at the T‐cell‐receptor delta‐chain locus. This may reflect another tumor‐suppressor‐gene locus at 14q11.2, or may be the consequence of a specific genomic rearrangement of this region. In addition, these allelic losses occurred with high frequency in all tumor grades and stages and in all histological sub‐types. These findings suggest that the genetic alteration of chromosome 14 is common and crucial during nasopharyngeal‐carcinoma development. Int. J. Cancer 78:153–156, 1998.© 1998 Wiley‐Liss, Inc.
Subject(s)allele , biology , cancer research , carcinogenesis , chromosome , deletion mapping , gene , genetics , locus (genetics) , loss of heterozygosity , medicine , microsatellite , nasopharyngeal carcinoma , radiation therapy , tumor suppressor gene
SCImago Journal Rank2.475

Seeing content that should not be on Zendy? Contact us.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here